Core 1-Derived Mucin-Type O-Glycosylation Protects Against Spontaneous Gastritis And Gastric Cancer

Fei Liu,Jianxin Fu,Kirk Bergstrom,Xindi Shan,J. Michael Mcdaniel,Samuel Mcgee,Xia Bai,Weichang Chen,Lijun Xia
DOI: https://doi.org/10.1084/jem.20182325
2020-01-01
Abstract:Core 1-derived mucin-type O-glycans (O-glycans) are a major component of gastric mucus with an unclear role. To address this, we generated mice lacking gastric epithelial O-glycans (GEC C1galt1(-/-)). GEC C1galt1(-/-) mice exhibited spontaneous gastritis that progressed to adenocarcinoma with similar to 80% penetrance by 1 yr. GEC C1galt1(-/-) gastric epithelium exhibited defective expression of a major mucus forming O-glycoprotein Muc5AC relative to WT controls, which was associated with impaired gastric acid homeostasis. Inflammation and tumorigenesis in GEC C1galt1(-/-) stomach were concurrent with activation of caspases 1 and 11 (Casp1/11)-dependent inflammasome. GEC C1galt1(-/-) mice genetically lacking Casp1/11 had reduced gastritis and gastric cancer progression. Notably, expression of Tn antigen, a truncated form of O-glycan, and CASP1 activation was associated with tumor progression in gastric cancer patients. These results reveal a critical role of O-glycosylation in gastric homeostasis and the protection of the gastric mucosa from Casp1-mediated gastric inflammation and cancer.
What problem does this paper attempt to address?